AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Syn stock forecast12/8/2022 ![]() ![]() Admiral Markets Pty Ltd (ABN 63 151 613 839) ("Admirals") holds an Australian Financial Services Licence (AFSL) to carry on financial services business in Australia, limited to the financial services covered by its AFSL no. Systematic retrieval of data or other content from, whether to create or compile, post to other websites, directly or indirectly, as text, video or audio, a collection, compilation, database or directory, is prohibited absent our express prior written consent.Risk warning: The information on the website is not targeted to any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Any other use, including for any commercial purposes, is strictly prohibited without our express prior written consent. You may use and the contents contained in solely for your own individual non-commercial and informational purposes only. Liable for your own investment decisions and agree to the Users should not base their investment decision upon. is a research service that provides financial data and technical analysis of publicly traded stocks.Īll users should speak with their financial advisor before buying or selling any securities. Given the latest developments, we cannot determine the next direction as it may go both ways. Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Synthetics Biologics Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance. Since the stock is closer to the support from accumulated volume at $0.92 (1.31%) #Syn stock forecast fullIf Synthetics Biologics Inc takes out the full calculated possible swing range there will be an estimated 12.52% move between the lowest and the highest trading price during the day. Which gives a possible trading interval of +/-$0.0585 (+/-6.26%) up or down from last closing price. Trading Expectations For The Upcoming Trading Day Of Friday 21stįor the upcoming trading day on Friday, 21st we expect Synthetics Biologics Inc to open at $0.92, and during the day (based on 14 day Average True Range), There is a buy signal from a pivot bottom found 1 days ago.) (This stock has low daily movements and this gives low risk. For the last week the stock has had daily average volatility of 0.778% However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.0350 between high and low, or 3.89%. In general the stock tends to have very controlled movements and therefore the general risk is considered very low. Synthetics Biologics Inc finds support from accumulated volume at $0.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested. The very low volume increases the risk and reduces the other technical signals issued. This causes a divergence and may be considered as an early warning, but it may not be. Volume fell during the last trading day while the price increased. A break-up above any of these levels will issue buy signals. On corrections up, there will be some resistance from the lines at $0.99 and $1.17. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. The Synthetics Biologics Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Further rise is indicated until a new top pivot has been found. A buy signal was issued from a pivot bottom point on Wednesday, October 19, 2022, and so far it has risen 1.32%. ![]()
0 Comments
Read More
Leave a Reply. |